SOPHiA GENETICS Stock (NASDAQ:SOPH)


ForecastOwnershipChartTranscripts

Previous Close

$4.25

52W Range

$2.58 - $4.92

50D Avg

$3.80

200D Avg

$3.41

Market Cap

$280.62M

Avg Vol (3M)

$90.01K

Beta

1.10

Div Yield

-

SOPH Company Profile


SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CH

Employees

423

IPO Date

Jul 23, 2021

Website

SOPH Performance


Latest Earnings Call Transcripts


Q2 25Aug 05, 25 | 8:00 AM
Q1 25May 10, 25 | 8:00 AM
Q4 24Mar 04, 25 | 8:00 AM

Peer Comparison


TickerCompany
SLPSimulations Plus, Inc.
SNWVSANUWAVE Health, Inc.
SLNSilence Therapeutics plc
MASS908 Devices Inc.
NNOXNano-X Imaging Ltd.
HUMAHumacyte, Inc.
NRCNational Research Corporation
TBRGTruBridge, Inc.
DHDefinitive Healthcare Corp.
VYGRVoyager Therapeutics, Inc.